|
|
 |
|
Viewing report
|
|
|
|
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
GBI Research, Sep 2011, Pages: 114
“Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets”, which provides insights into drivers, barriers and trends in the outsourcing of drug development tin the global pharmaceutical and biotechnology industry. The report profiles top 20 contract research organization in Asia-Pacific and provides business overview, business snapshot and the list of alliances made in the period 2005 to 2010
In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by a team of experts.
Scope
The scope of this report includes:
- Analysis of drivers and barriers in the outsourcing of drug development processes
- Analysis of different functional models in the global CRO industry
- Analysis of key reasons for the pharmaceutical industry to outsource drug development
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Identify the top 20 contract research organizations in Asia-pacific
- Identify major international pharmaceutical companies who have made alliances with the Asia-Pacific CROs
- Understand the service offerings of major CROs in the Asia-Pacific
|
|
|
|
